This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Griepp , MD Professor in Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai , was named as the new President of the HeartValve Society ( HVS ) at the 2024 HVS Annual Meeting on Wednesday, February 21, in Boston.
Michael Rinaldi , an interventional cardiologist and the medical director of the structural heart program at Atrium Health Sanger Heart & Vascular Institute. "We We have been eagerly anticipating the opportunity to bring this innovative technology to our community.
In recent years, artificial intelligence (AI) has been used to improve the precision of valvular heart disease diagnosis and treatment. It has the ability to identify and risk stratify patients with valvular heart disease and holds promise in improving the innovation of new treatments through shorter, safer and more effective clinical trials.
This year, session topics will explore academic and systematic considerations on the basics of the aortic valve to the latest trends, various surgical methods, and treatments employing experts from various fields. There will also be an in-depth discussion on the lifelong management of aortic valve surgery patients.
mtaschetta-millane Mon, 07/29/2024 - 09:02 July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing patient care through structural heartinnovation, addressing large unmet patient needs and supporting sustainable long-term growth.
Bileaflet mechanical heartvalves (MHV) remain a viable option for aortic valve replacement, particularly for younger patients and patients from low- and middle-income countries and underserved communities. Despite their exceptional durability, MHV recipients are at increased risk of thromboembolic complications.
In such scenarios, cardiologists’ primary form of treatment for children with coronary heart disease is a heartvalve implant. Unfortunately, the traditional pulmonary valves have a fixed diameter that can’t match the size of the child’s heart over time.
Getty Images milla1cf Thu, 01/04/2024 - 11:04 January 4, 2024 — Laguna Tech USA , a privately-held medical technology company dedicated to innovations in structural heart solutions to broaden useability and applicability for patients, today announced that a record number five patients were successfully treated at a single center on the same day with (..)
The center will explore the potential of these devices and treatments as the standard of care in managing tricuspid and mitral valve disorders. According to Kodali, the Center’s wealth of expertise and experience will help drive these advances.
milla1cf Tue, 04/23/2024 - 15:53 April 23, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. This next-generation surgical aortic tissue valve is designed to facilitate ease of use at implant and lifetime patient management.
Getty Images milla1cf Thu, 06/13/2024 - 20:38 June 13, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. 3 Based on internal test report D00997823, Avalus Ultra Full Valve Stiffness Design Verification Report.
The Society for Cardiovascular Angiography & Interventions (SCAI) kicks off its SCAI Scientific Sessions 2024 this week, May 2-4 in Long Beach, CA, bringing together more than 1,800 clinicians, scientists, researchers, and innovators in the field of interventional cardiology and endovascular medicine.
TEE is also a valuable tool for minimally invasive heart surgeries and procedures, transforming the treatment of damaged heartvalves and congenital heart defects [2]. As a pioneer and leading innovator in cardiac ultrasound, our 3D ultrasound technology plays a critical role in many cardiac procedures.
Barr’s death at 39 from sudden cardiac arrest was caused by mitral valve prolapse—a heartvalve defect that can affect the heart’s ability to pump blood. Makkar: Also, patients have earlier access to the most innovative treatments because we are often leading clinical trials and using new devices and novel approaches.
The teams will combine innovative engineering designs, antithrombotic slippery hydrophilic (SLIC) coatings, wireless power transfer systems, magnetically levitated driving systems and preclinical device testing to achieve their goal. He is an expert in prosthetic heartvalves and cardiovascular biomechanics, biomaterials and devices.
The patient underwent a successful TAVI procedure using the XL-Myval 32 mm transcatheter heartvalve (THV) via an anterior right mini-thoracotomy with a direct aortic approach. The patient recovered well post-operatively with good hemodynamic resolution.
Additionally, the company also offers the first fully automated 3D quantification of mitral regurgitation (MR) volumes* designed to provide reproducible, efficient analysis helps clinicians make better-informed decisions for patients with heartvalve disease. “As
These included innovation characteristics, external and internal settings, and individual dynamics. IntroductionEnhanced Recovery After Surgery (ERAS) protocols represent a paradigm shift in perioperative care, aim to optimize patient outcomes and accelerate recovery.
At ADN CoE, we are dedicated to empowering medical professionals through a diverse range of fellowship programs meticulously crafted to nurture expertise and innovation. We offer a comprehensive array of courses spanning from advanced structural heart interventions to Advanced Urology, Bariatric surgery, Cardiovascular Surgery, and beyond.
Ibrahim Halil Kurt, President of HeartValve Disease in the Turkish Society of Cardiology, the event showcased the latest techniques and innovations in this life-saving procedure. Under the guidance of Prof.
Catheter-based procedures offer an alternative for patients who are not candidates for open-heart surgery. Makkar: For decades, tricuspid regurgitation was largely overlooked, often addressed only during surgeries for other heartvalves.
The center will explore the potential of these devices and treatments as the standard of care in managing tricuspid and mitral valve disorders. According to Kodali, the Center’s wealth of expertise and experience will help drive these advances.
Ibrahim Halil Kurt, President of HeartValve Disease in the Turkish Society of Cardiology, the event showcased the latest techniques and innovations in this life-saving procedure. Under the guidance of Prof.
At ADN CoE, we are dedicated to empowering medical professionals through a diverse range of fellowship programs meticulously crafted to nurture expertise and innovation. We offer a comprehensive array of courses spanning from advanced structural heart interventions to Advanced Urology, Bariatric surgery, Cardiovascular Surgery, and beyond.
In a remarkable leap forward for pediatric cardiac care, a groundbreaking partial heart transplant procedure has emerged as a beacon of hope for infants facing severe congenital heart conditions. This unique case presented an opportunity to utilize the heart after cardiac death through standard surgical techniques.
His industry roles have included serving as Chief Medical Officer for HLT Medical, a transcatheter heartvalve company, as Chief of Cardiology with Optum/United Health subsidiary SCA Health, and as Medical Director for clinical research organization Medpace.
Under the expert guidance of our seasoned instructors and anatomy specialist, this session offered a wealth of practical insights, allowing attendees to delve into the intricacies of heartvalve anatomy.
Background Percutaneous pulmonary valve implantation (PPVI) has emerged as a less invasive alternative for treating severe pulmonary regurgitation after tetralogy of Fallot (TOF) repair in patients with a native right ventricular outflow tract (RVOT).
Under the expert guidance of our seasoned instructors and anatomy specialist, this session offered a wealth of practical insights, allowing attendees to delve into the intricacies of heartvalve anatomy.
About Aortic Stenosis Aortic valve stenosis - or aortic stenosis - is a type of heartvalve disease (valvular heart disease). The valve between the lower left heart chamber and the body's main artery (aorta) is narrowed and doesn't open fully.
Food and Drug Administration (FDA) approval of its TriClip, a first-of-its-kind device to repair leaky tricuspid heartvalve, for which more than 1.6 Abbott has announced U.S million people in the U.S. are estimated to be affected. The device has already been used to treat more than 10,000 people with TR. 10.21037/cdt.2019.09.11.
Tricuspid regurgitation (TR) is a common and serious disease for which open heart surgery and symptomatic pharmacologic treatment are the current standard treatment options. Owing to high mortality risk, access to open heart surgery is severely restricted and is not considered an option for most patients with TR.
Widely recognized for pioneering innovative concepts and techniques in TAVR, Tang has set contemporary standards in the field. His impressive international academic collaborations include the establishment of multiple global registries and the training of heart teams in structural heart imaging and procedures worldwide.
The conference features live demonstrations, training workshops, simulations, clinical cases, late-breaking trials, innovations, and selected scientific abstracts. The scope of the meeting extends across the vast field of interventional cardiology, with specific emphasis on coronary, valve, and structural interventions.
Widely recognized for pioneering innovative concepts and techniques in TAVR, Tang has set contemporary standards in the field. His impressive international academic collaborations include the establishment of multiple global registries and the training of heart teams in structural heart imaging and procedures worldwide.
Catheter-based procedures offer an alternative for patients who are not candidates for open-heart surgery. Makkar: For decades, tricuspid regurgitation was largely overlooked, often addressed only during surgeries for other heartvalves.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content